Renal Business Today

Infection Control

Infections are the second leading cause of death among dialysis patients, according to the U.S. Renal Data System. Hand hygiene, as well as ensuring that surfaces, objects, devices and equipment are properly, disinfected and sterilized, is essential in preventing healthcare-acquired infections (HAIs) and ensuring the safety of dialysis patients and renal professionals.

CMS releases dialysis conditions for coverage

WASHINGTON—On April 4, the Centers for Medicare & Medicaid Services published the final rule to modernize the Medicare conditions for coverage of dialysis centers in the United States. ...More
April 11, 2008
Posted in News, Government & Regulation, Practice Management
Baxter recalls heparin

WASHINGTON—Baxter Healthcare Corp. has stopped manufacturing and has recalled all multiple-dose vials of the injectable blood-thinning drug heparin after receiving more than 300 reports of allergic reactions since the start of the year. Four people have died after receiving ...More
March 20, 2008
Posted in Articles, Business, Government & Regulation
Baxter recalls remaining heparin lots

DEERFIELD, Ill.—Baxter International Inc. said Feb. 28 that it is going to voluntarily recall all remaining lots and doses of its heparin sodium injection multi-dose, single-dose vials and HEP-LOCK heparin flush products. ...More
February 28, 2008
Posted in News, Business, Clinical & Pharma, Government & Regulation, Practice Management
Baxter stops heparin production after hundreds of adverse events reported

WASHINGTON—Baxter Healthcare Corp. has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug heparin after receiving more than 300 reports of allergic reactions since the start of the year. ...More
February 12, 2008
Posted in News, Business, Clinical & Pharma, Government & Regulation, Practice Management
Alcavis, HDC merge

GAITHERSBURG, Md.—Alcavis International Inc. and HDC Medical Inc. merged and formed a new company, Alcavis HDC LLC. The merger became official on February 1. "They’re very compatible to work with," said Hugh Doss, who founded HDC Medical. "Merging with them would be better ...More
January 29, 2008
Posted in Articles, Business, Clinical & Pharma, Practice Management
Employee Safety in the Dialysis Clinic

As in any other healthcare setting, there are risks for employees who provide dialysis care. They may be exposed to sharps, infectious diseases, falls or back injury from lifting heavy patients. These potential injuries can result in lost employee time, and also in costly ...More
January 7, 2008
Posted in Articles, Business, Clinical & Pharma, Government & Regulation
Alcavis, HDC merge

GAITHERSBURG, Md.—Alcavis International Inc. and HDC Medical Inc. have merged and formed a new company, Alcavis HDC LLC. The merger was announced late last year and became official on January 1. Alcavis focuses on infection control in the dialysis setting. Products include ...More
January 7, 2008
Posted in Articles, Business, Clinical & Pharma, Practice Management
Alcavis, HDC to merge

GAITHERSBURG, Md.—Alcavis International Inc. and HDC Medical Inc. announced today they will merge and form a new company, Alcavis HDC LLC. ...More
December 10, 2007
Posted in News, Clinical & Pharma, Practice Management
Service Profile: Night Owl Sleep Resources

Night Owl Sleep Resources is a unique, patented program that offers sleep laboratory services in a patient’s home. Since dialysis patients frequently experience sleep disturbances and other sleep-related problems, oftentimes they will be referred for a sleep study. But ...More
November 30, 2007
Posted in Articles, Government & Regulation
Renal Business Today now a member of BPA Worldwide

PHOENIX—Virgo Publishing said Renal Business Today magazine is now an official member of BPA Worldwide, a nonprofit media auditing organization. The Renal Business Today audit verifies the 20,026 circulation, the job titles and the facilities of the subscribers. “Renal ...More
August 1, 2007
Posted in Articles, Business, Clinical & Pharma